Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Subviral Agents01:29

Subviral Agents

565
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
565
Real Number System01:27

Real Number System

1.1K
The real number system includes all numbers used for counting, measuring, and comparing quantities. Natural numbers are the basic counting numbers: 1, 2, 3, and so on. Integers expand this set by including zero and negative whole numbers: ..., –3, –2, –1, 0, 1, 2, .... Rational numbers are those that can be expressed as the ratio of two integers m/n, where n≠0. This includes fractions like 1/2​, integers such as 46, and decimals that terminate, such as 0.17, or...
1.1K
Air-entraining Agents01:27

Air-entraining Agents

272
Air-entraining agents improve the durability and workability of concrete in climates with frequent freezing and thawing. These agents prevent cracks by introducing small air bubbles into the mix, creating spaces accommodating water expansion when temperatures drop. The air-entraining agents lower the surface tension of water, forming stable, small air bubbles. This method is more effective than having accidental large voids, as the intentional, smaller, and evenly distributed air voids improve...
272
Masking and Demasking Agents01:19

Masking and Demasking Agents

3.6K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
3.6K
Real Number Operations01:27

Real Number Operations

321
The concept of real numbers includes all the values that can be represented on a continuous number line. The system began with basic counting values used for enumeration. It later expanded to include values that represent the absence of quantity and opposites of the counting values. When situations required expressing parts of a whole or dividing quantities evenly, values capable of representing such proportions were developed. When written using decimal notation, these values can end or repeat...
321
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of Novel Radiopharmaceuticals for SPECT and PET.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Integration of 2D Materials in Radial van der Waals Heterostructure Metasurfaces.

ACS nano·2026
Same author

Cross-sectional study of citations from Brazilian Vascular Journal and Brazilian authors between the years 2016-2024.

Jornal vascular brasileiro·2025
Same author

Validation of an artificial intelligence program in the characterization of breast nodules by ultrasound.

Clinical imaging·2025
Same author

Editorial: Women in science - nuclear medicine 2024.

Frontiers in medicine·2025
Same author

Shedding Light on Hidradenitis Suppurativa Activity: A Pilot Study to Evaluate the Potential of [<sup>99m</sup>Tc]Tc-Anti-TNF-Alpha Scintigraphy.

Pharmaceuticals (Basel, Switzerland)·2025
Same journal

Design, Synthesis and Biological Evaluation of New Oxazolidinone Antimicrobial Agents with Low Monoamine Oxidase A Inhibition.

Drug design, development and therapy·2026
Same journal

Therapeutic Potential of Ziyuglycosides from <i>Sanguisorba officinalis</i>: Anticancer and Immunomodulatory Properties.

Drug design, development and therapy·2026
Same journal

Pterostilbene in Oxidative Stress-Related Diseases: Context-Dependent Regulation of Redox Homeostasis and Translational Challenges.

Drug design, development and therapy·2026
Same journal

ED50 and ED95 of Remimazolam Combined with Sufentanil for Sedation During Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: A Prospective Dose-Finding Study.

Drug design, development and therapy·2026
Same journal

Metabolomics-Driven Precision Prevention and Treatment of Heart Failure with Traditional Chinese Medicine: From Mechanistic Insights to Metabolic Network Regulation.

Drug design, development and therapy·2026
Same journal

Beyond Terminal Blockade: A Mechanism-Based Approach to Complement Inhibitor Selection in Paroxysmal Nocturnal Hemoglobinuria.

Drug design, development and therapy·2026
See all related articles

Related Experiment Video

Updated: Feb 3, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

2.0K

Copper-64: a real theranostic agent.

Bianca Gutfilen1, Sergio Al Souza1, Gianluca Valentini2

  • 1Department of Radiology, School of Medicine, Laboratório de Marcação de Células e Moléculas (LMCM), Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, bianca.gutfilen@gmail.com.

Drug Design, Development and Therapy
|October 17, 2018
PubMed
Summary
This summary is machine-generated.

New radioactive tracer Copper-64 (64Cu) shows promise as a theranostic agent for cancer imaging and treatment. Its use in 64CuCl2 highlights a revolutionary advancement in nuclear medicine for positron emission tomography.

Keywords:
Copper-64PETcancerradiopharmaceuticaltheranostic

More Related Videos

Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria
05:57

Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria

Published on: October 4, 2024

1.4K
[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst
09:12

[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst

Published on: May 21, 2019

9.9K

Related Experiment Videos

Last Updated: Feb 3, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

2.0K
Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria
05:57

Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria

Published on: October 4, 2024

1.4K
[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst
09:12

[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst

Published on: May 21, 2019

9.9K

Area of Science:

  • Nuclear Medicine
  • Radiopharmaceutical Development
  • Theranostics

Background:

  • Copper (Cu) is vital in biological functions, with altered levels linked to cancer and neurodegenerative diseases.
  • The human copper transporter 1 (hCtr1) imports Cu(I) into cells.
  • Theranostics, using a single agent for diagnosis and treatment, is a growing field in medicine.

Purpose of the Study:

  • To review the clinical development and application of Copper-64 (64Cu) as a theranostic agent.
  • To highlight the potential of 64CuCl2 for various tumor types.
  • To discuss the significance of 64Cu in positron emission tomography (PET) imaging.

Main Methods:

  • Review of recent literature on 64CuCl2 in theranostics.
  • Analysis of 64Cu's physical properties for diagnostic and therapeutic use.
  • Examination of clinical data regarding 64CuCl2 for tumor imaging.

Main Results:

  • 64Cu possesses advantageous physical properties for diagnostic and therapeutic applications.
  • 64CuCl2 has shown potential as a theranostic agent for imaging various tumors.
  • No adverse or clinically observable pharmacological effects of 64CuCl2 have been reported.

Conclusions:

  • 64Cu is a revolutionary radiopharmaceutical for PET imaging.
  • 64CuCl2 opens new possibilities in the field of theranostics for oncology.
  • Further clinical development of 64Cu-based agents is warranted.